Methocarbamol

Product NDC: 65977-5034
11-digit product format: 659775034
Labeler code: 65977
Product ID: 65977-5034_98457ee9-35be-4d2f-84c2-b3283e553bbd
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Methocarbamol
Dosage form: TABLET
Route: ORAL
Labeler: Hetero Drugs Limited Unit III
Application: ANDA090200
Marketing category: ANDA
Marketing start: 2009-11-06
Marketing end: 0000-00-00
Substance: METHOCARBAMOL
Active strength: 750 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	65977-5034		I	Inactivated by FDA	2026-08-03
excluded package	package	65977-5034	65977-5034-0	I	Inactivated by FDA	2026-08-03
excluded package	package	65977-5034	65977-5034-1	I	Inactivated by FDA	2026-08-03
excluded package	package	65977-5034	65977-5034-2	I	Inactivated by FDA	2026-08-03
excluded package	package	65977-5034	65977-5034-3	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 110 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	65977-5034-0	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	65977-5034-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	65977-5034-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	65977-5034-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	65977-5034-0	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	65977-5034-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	65977-5034-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	65977-5034-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	65977-5034-0	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	65977-5034-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	65977-5034-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	65977-5034-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	65977-5034-0	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	65977-5034-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	65977-5034-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	65977-5034-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	65977-5034-0	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	65977-5034-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	65977-5034-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	65977-5034-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	65977-5034-0	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	65977-5034-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	65977-5034-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	65977-5034-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	65977-5034-0	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	65977-5034-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	65977-5034-2	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	65977-5034-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	65977-5034-0	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	65977-5034-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	65977-5034-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	65977-5034-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	65977-5034-0	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	65977-5034-3	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	65977-5034-2	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	65977-5034-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	65977-5034-0	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	65977-5034-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	65977-5034-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	65977-5034-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	65977-5034-0	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	65977-5034-3	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	65977-5034-2	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	65977-5034-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	65977-5034-0	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	65977-5034-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	65977-5034-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	65977-5034-1	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A090200-001	METHOCARBAMOL	METHOCARBAMOL	500MG	TABLET / ORAL	AA		2009-11-06
A090200-002	METHOCARBAMOL	METHOCARBAMOL	750MG	TABLET / ORAL	AA		2009-11-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A090200-001	AA
A090200-002	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090200-001	AA	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090200-002	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-001	AA	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-002	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090200-001	AA	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090200-002	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-001	AA	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-002	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-001	AA	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-002	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-001	AA	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-002	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-001	AA	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-002	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-001	AA	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-002	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-001	AA	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-002	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090200-001	AA	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090200-002	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-001	AA	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-002	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-001	AA	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-002	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-001	AA	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-002	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090200-001	AA	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090200-002	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-001	AA	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-002	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090200-001	AA	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090200-002	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090200-001	AA	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090200-002	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090200-001	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090200-002	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090200-001	AA	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090200-002	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090200-001	AA	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090200-002	AA	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
492965be-47bc-38cf-57c4-5c5e0343abe5	Product name	6	20211028
02a01e9c-3f4e-c0ee-6542-be865127aea3	Product name	8	20190205

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
65977-5034-0	b3136363-6fcb-486d-b752-d53a1f8e2d69
65977-5034-1	b3136363-6fcb-486d-b752-d53a1f8e2d69
65977-5034-2	b3136363-6fcb-486d-b752-d53a1f8e2d69
65977-5034-3	b3136363-6fcb-486d-b752-d53a1f8e2d69

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65977-5034-0	Methocarbamol	30 in 1 BOTTLE	TABLET	30	4
65977-5034-1	Methocarbamol	60 in 1 BOTTLE	TABLET	60	4
65977-5034-2	Methocarbamol	100 in 1 BOTTLE	TABLET	100	4
65977-5034-3	Methocarbamol	500 in 1 BOTTLE	TABLET	500	4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Methocarbamol	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
Methocarbamol	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
colloidal silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
Hydroxypropyl Cellulose, Low Substituted	INACTIVE INGREDIENT	2165RE0K14	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
polyethylene glycol	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
povidone K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
Sodium Starch Glycolate Type A Potato	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4
stearic acid	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65977-5034	METHOCARBAMOL TABLET [HETERO DRUGS LIMITED UNIT III]	4	Legacy NDC, 4 package rows	20100301_b3136363-6fcb-486d-b752-d53a1f8e2d69.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 23 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Methocarbamol	METHOCARBAMOL	American Health Packaging	d842fe4e-fc46-4d70-9ca3-b47191672f96	2026-07-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Unit Dose Solutions, Inc.	5539d4f6-1192-2770-e063-6394a90a1e50	2026-06-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
METHOCARBAMOL	METHOCARBAMOL	DIRECT RX	31508051-c9cb-149b-e054-00144ff88e88	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	AvPAK	be37bc85-6a41-00d8-e053-2a95a90ae504	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Northwind Health Company, LLC	f31ccb09-7a9a-60af-e053-2995a90a6e97	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Northwind Health Company, LLC	df63611f-90e4-6bbe-e053-2a95a90a2aad	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Aphena Pharma Solutions - Tennessee, LLC	18810520-3040-4802-e063-6294a90a1ec0	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Cardinal Health 107, LLC	05b287d3-5004-4d8b-9ebe-a96caa2b8d89	2025-11-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	9aed8304-fa4e-49d6-bd81-fcb3e4cc6173	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	ff55df39-e314-4120-8fab-3757cbe5a872	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	069045f1-d699-41d0-b674-cdb71cd5fbd0	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Preferred Pharmaceuticals Inc.	eed9ebd1-c243-4e82-bf4e-5fec370e722e	2025-02-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Coupler LLC	2cee3893-70b7-6c2c-e063-6394a90aa79a	2025-01-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Advanced Rx Pharmacy of Tennessee, LLC	f4e98f9f-b20b-8608-e053-2a95a90aa6b0	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Bryant Ranch Prepack	3f47c39b-9373-454f-9a4e-ba6dd65dd7a4	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Bryant Ranch Prepack	add9e47f-11ac-e10d-bfc2-b9c52aa08fa5	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	NuCare Pharmaceuticals,Inc.	9d6024b2-ee1a-3a79-e053-2a95a90a1bf4	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	NuCare Pharmaceuticals, Inc.	3e89a426-c741-2f44-e054-00144ff8d46c	2024-08-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Aphena Pharma Solutions - Tennessee, LLC	1880efb2-b97e-1e4d-e063-6294a90ab3e3	2024-05-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	XLCare Pharmaceuticals Inc.	f8bfb5cb-b7d0-4e09-b6bd-97a51d82c991	2024-02-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
125OD7737X	METHOCARBAMOL	532-03-6	METHOCARBAMOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197943	methocarbamol 500 MG Oral Tablet	PSN	b3136363-6fcb-486d-b752-d53a1f8e2d69	4
197944	methocarbamol 750 MG Oral Tablet	PSN	b3136363-6fcb-486d-b752-d53a1f8e2d69	4
197943	methocarbamol 500 MG Oral Tablet	SCD	b3136363-6fcb-486d-b752-d53a1f8e2d69	4
197944	methocarbamol 750 MG Oral Tablet	SCD	b3136363-6fcb-486d-b752-d53a1f8e2d69	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
65977-5034-0	65977503400	30 in 1 BOTTLE	Historical
65977-5034-1	65977503401	60 in 1 BOTTLE	Historical
65977-5034-2	65977503402	100 in 1 BOTTLE	Historical
65977-5034-3	65977503403	500 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Methocarbamol - Hetero Drugs Limited Unit III	Hetero Drugs Limited Unit III	2009-12-17	HUMAN PRESCRIPTION DRUG LABEL	4